Verition Fund Management LLC Rigel Pharmaceuticals Inc Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.72 - $1.56 $8,258 - $17,893
11,470 New
11,470 $16,000
Q2 2023

Aug 14, 2023
SELL
$1.12 - $1.82 $38,600 - $62,726
-34,465 Reduced 27.86%
89,235 $115,000
Q1 2023

May 15, 2023
BUY
$1.25 - $2.0 $154,625 - $247,400
123,700 New
123,700 $163,000
Q3 2022

Nov 14, 2022
BUY
$1.1 - $12.2 $11,212 - $124,354
10,193 New
10,193 $12,000

Others Institutions Holding RIGL

# of Institutions
9
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.81B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email